Rhoen Klinikum AG
F:RHKU
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Rhoen Klinikum AG
F:RHKU
|
DE |
|
I
|
IMPACT Growth Real Estate Investment Trust
SET:IMPACT
|
TH |
|
B
|
Boston Beer Company Inc
F:BBEA
|
US |
|
SPS Commerce Inc
F:S86
|
US |
|
J
|
Johnson & Johnson
XMUN:JNJ
|
US |
|
F
|
First Advantage Corp
XBER:0MS
|
US |
Wall St Price Targets
RHKU Price Targets Summary
Rhoen Klinikum AG
According to Wall Street analysts, the average 1-year price target for RHKU is 6.99 EUR with a low forecast of 6.1 EUR and a high forecast of 8.12 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RHKU's stock price target?
Price Target
6.99
EUR
According to Wall Street analysts, the average 1-year price target for RHKU is 6.99 EUR with a low forecast of 6.1 EUR and a high forecast of 8.12 EUR.
What is the Revenue forecast for Rhoen Klinikum AG?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Revenue has been -3%. The projected CAGR for the next 3 years is 5%.
What is the Gross Profit forecast for Rhoen Klinikum AG?
Projected CAGR
-4%
Over the last 14 years, the compound annual growth rate for Gross Profit has been -4%. The projected CAGR for the next 5 years is -4%.
What is the Operating Income forecast for Rhoen Klinikum AG?
Projected CAGR
24%
Over the last 14 years, the compound annual growth rate for Operating Income has been -11%. The projected CAGR for the next 3 years is 24%.
What is the Pre-Tax Income forecast for Rhoen Klinikum AG?
Projected CAGR
19%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been -10%. The projected CAGR for the next 3 years is 19%.
What is the Net Income forecast for Rhoen Klinikum AG?
Projected CAGR
20%
Over the last 14 years, the compound annual growth rate for Net Income has been -10%. The projected CAGR for the next 3 years is 20%.
